One-Shot eye injection aims to halt blinding disease
NCT ID NCT07392255
Summary
This study is testing a new, one-time injection called CTx001 for people with geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. The main goals are to see if the injection is safe and if it can slow down the damage to the retina. Researchers will follow 75 participants for up to 5 years to measure changes in their vision and eye structure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Midwest Eye Institute
RECRUITINGCarmel, Indiana, 46290, United States
-
Retina Foundation of the Southwest
RECRUITINGDallas, Texas, 75231, United States
-
Sierra Eye Associates
RECRUITINGReno, Nevada, 89502, United States
Conditions
Explore the condition pages connected to this study.